抗ウイルス薬の世界市場

【英語タイトル】Antiviral Drugs - Global Market Outlook (2016-2022)

Stratistics MRCが出版した調査資料(SMRC70523039)・商品コード:SMRC70523039
・発行会社(調査会社):Stratistics MRC
・発行日:2017年2月
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥477,250見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥603,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥862,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、抗ウイルス薬の世界市場について調査・分析し、抗ウイルス薬の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 抗ウイルス薬の世界市場:市場動向分析
- 抗ウイルス薬の世界市場:競争要因分析
- 抗ウイルス薬の世界市場:用途別
・B型肝炎用抗ウイルス薬
・C型肝炎用抗ウイルス薬
・ヘルペスウイルス
・HIV抗ウイルス薬
・インフルエンザ
・その他
- 抗ウイルス薬の世界市場:エンドユーザー別
・外来外科センター
・クリニック
・病院
- 抗ウイルス薬の世界市場:流通経路別
・院内薬局
・オンライン薬局
・小売薬局
- 抗ウイルス薬の世界市場:製品の種類別
・ジェネリック医薬品
・先発医薬品
- 抗ウイルス薬の世界市場:作用機序別
・ヌクレオチドポリメラーゼ阻害剤
・プロテアーゼ阻害剤
・逆転写酵素阻害剤
・その他
- 抗ウイルス薬の世界市場:主要地域別分析
- 抗ウイルス薬の北米市場規模(アメリカ市場等)
- 抗ウイルス薬のヨーロッパ市場規模
- 抗ウイルス薬のアジア市場規模(日本市場、中国市場、インド市場等)
・抗ウイルス薬の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.

HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.

Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.

Applications Covered:
• Hepatitis-B antivirals
• Hepatitis-C antivirals
• Herpes virus
• HIV antivirals
• Influenza
• Other Applications
o Pneumonia
o Flu

End-Users Covered:
• Ambulatory Surgical Centers
• Clinics
• Hospitals

Distribution Channels covered:
• Hospital Pharmacy Store
• Online Pharmacy
• Retail Pharmacy Store

Product Types Covered:
• Generic Drugs
• Branded Drugs

Action Mechanisms covered:
• Nucleotide polymerase inhibitor
• Protease inhibitors
• Reverse transcriptase inhibitors
• Other Action Mechanisms

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Antiviral Drugs Market, By Application
5.1 Introduction
5.2 Hepatitis-B antivirals
5.3 Hepatitis-C antivirals
5.4 Herpes virus
5.5 HIV antivirals
5.6 Influenza
5.7 Other Applications
5.7.1 Pneumonia
5.7.2 Flu

6 Global Antiviral Drugs Market, By End-User
6.1 Introduction
6.2 Ambulatory Surgical Centers
6.3 Clinics
6.4 Hospitals

7 Global Antiviral Drugs Market, By Distribution Channels
7.1 Introduction
7.2 Hospital Pharmacy Store
7.3 Online Pharmacy
7.4 Retail Pharmacy Store

8 Global Antiviral Drugs Market, By Product Type
8.1 Introduction
8.2 Generic Drugs
8.3 Branded Drugs

9 Global Antiviral Drugs Market, By Action Mechanism
9.1 Introduction
9.2 Nucleotide polymerase inhibitor
9.3 Protease inhibitors
9.4 Reverse transcriptase inhibitors
9.5 Other Action Mechanisms

10 Global Antiviral Drugs Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbott Laboratories
12.2 AbbVie, Inc.
12.3 Aurobindo Pharma
12.4 Bristol-Myers-Squibb
12.5 Cipla
12.6 Dr. Reddy’s Laboratories Ltd
12.7 F. Hoffmann-La Roche AG
12.8 Gilead Sciences
12.9 GlaxoSmithKline plc.
12.10 Johnson and Johnson
12.11 MedImmune/AstraZeneca
12.12 Merck & Co
12.13 Mylan N.V.
12.14 Roche Diagnostics
12.15 Schering-Plough
12.16 Teva Pharmaceutical Industries Ltd.

List of Tables
Table 1 Global Antiviral Drugs Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 3 Global Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 4 Global Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 5 Global Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 6 Global Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 7 Global Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 8 Global Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 9 Global Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 10 Global Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 11 Global Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 12 Global Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 13 Global Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 14 Global Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 15 Global Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 16 Global Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 17 Global Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 18 Global Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 19 Global Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 20 Global Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 21 Global Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 22 Global Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 23 Global Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 24 Global Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 25 Global Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 26 Global Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 27 North America Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 28 North America Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 29 North America Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 30 North America Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 31 North America Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 32 North America Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 33 North America Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 34 North America Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 35 North America Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 36 North America Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 37 North America Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 38 North America Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 39 North America Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 40 North America Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 41 North America Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 42 North America Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 43 North America Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 44 North America Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 45 North America Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 46 North America Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 47 North America Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 48 North America Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 49 North America Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 50 North America Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 51 North America Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 52 North America Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 53 Europe Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 54 Europe Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 55 Europe Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 56 Europe Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 57 Europe Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 58 Europe Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 59 Europe Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 60 Europe Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 61 Europe Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 62 Europe Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 63 Europe Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 64 Europe Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 65 Europe Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 66 Europe Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 67 Europe Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 68 Europe Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 69 Europe Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 70 Europe Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 71 Europe Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 72 Europe Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 73 Europe Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 74 Europe Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 75 Europe Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 76 Europe Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 77 Europe Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 78 Europe Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 79 Asia Pacific Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 80 Asia Pacific Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 81 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 82 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 83 Asia Pacific Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 84 Asia Pacific Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 85 Asia Pacific Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 86 Asia Pacific Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 87 Asia Pacific Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 88 Asia Pacific Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 89 Asia Pacific Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 90 Asia Pacific Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 91 Asia Pacific Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 92 Asia Pacific Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 93 Asia Pacific Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 94 Asia Pacific Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 95 Asia Pacific Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 96 Asia Pacific Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 97 Asia Pacific Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 98 Asia Pacific Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 99 Asia Pacific Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 100 Asia Pacific Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 101 Asia Pacific Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 102 Asia Pacific Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 103 Asia Pacific Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 104 Asia Pacific Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 105 RoW Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 106 RoW Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 107 RoW Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 108 RoW Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 109 RoW Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 110 RoW Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 111 RoW Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 112 RoW Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 113 RoW Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 114 RoW Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 115 RoW Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 116 RoW Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 117 RoW Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 118 RoW Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 119 RoW Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 120 RoW Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 121 RoW Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 122 RoW Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 123 RoW Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 124 RoW Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 125 RoW Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 126 RoW Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 127 RoW Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 128 RoW Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 129 RoW Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 130 RoW Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)



★調査レポート[抗ウイルス薬の世界市場] (コード:SMRC70523039)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗ウイルス薬の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆